Cardiac involvement in the catastrophic antiphospholipid syndrome (CAPS): Lessons from the "CAPS registry "

被引:6
作者
Pons, Isaac [1 ,2 ,3 ]
Jerez, Alba [1 ,2 ,4 ]
Espinosa, Gerard [1 ,2 ]
Rodriguez-Pinto, Ignasi [1 ,2 ]
Erkan, Doruk [5 ]
Shoenfeld, Yehuda [6 ]
Cervera, Ricard [1 ,2 ]
机构
[1] Univ Barcelona, Reference Ctr Syst Autoimmune Dis UEC CSUR Catala, Dept Autoimmune Dis, ERNReCONNET,Hosp Clin, Barcelona, Catalonia, Spain
[2] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Catalonia, Spain
[3] Univ Vic, Univ Cent Catalunya uVic UCC, Dept Internal Med, Althaia Xarxa Assistencial Univ Manresa,Fac Med, Manresa, Catalonia, Spain
[4] Hosp Mutua Terrassa, Dept Internal Med, Syst Autoimmune Dis Unit, Terrassa, Catalonia, Spain
[5] Hosp Special Surg, Barbara Volcker Ctr Women & Rheumat Dis, Weill Cornell Med, New York, NY USA
[6] Reichman Univ, Sheba Med Ctr, Zabludowicz Ctr Autoimmune Dis, Herzelya, Israel
关键词
Catastrophic antiphospholipid syndrome; Cardiac involvement; Antiphospholipid syndrome; Valve involvement; Antiphospholipid antibodies; Lupus anticoagulant; VALVULAR HEART-DISEASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; FOLLOW-UP; VALVE DISEASE; PATIENT; ANTIBODIES; MANIFESTATIONS; CLASSIFICATION; ECHOCARDIOGRAPHY; ENDOCARDITIS;
D O I
10.1016/j.semarthrit.2024.152439
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To analyze the demographic, clinical, and laboratory characteristics of catastrophic antiphospholipid syndrome (CAPS) patients with cardiac involvement, and to identify the factors associated with this cardiac involvement. Material and methods: Based on the analysis of the "CAPS Registry", the demographic, clinical, and serological characteristics of patients with cardiac involvement were analyzed. Cardiac involvement was defined as heart failure, valvular disease, acute myocardial infarction, pericardial effusion, pulmonary arterial hypertension, systolic dysfunction, intracardiac thrombosis, and microvascular disease. Univariate and multivariate analysis was used for multiple comparisons. Results: 749 patients (293 [39 %] women and mean age 38.1 +/- 16.2 years) accounting for 778 CAPS events were included, of them 404 (52 %) had cardiac involvement. The main cardiac manifestations were heart failure in 185/377 (55 %), valve disease in 116/377 (31 %), and acute myocardial infarction in 104/378 (28 %). Of 58 patients with autopsy/biopsy, 48 (83 %) had cardiac thrombotic microangiopathy, Stroke (29% vs. 21 %, p = 0.012), transient cerebral vascular accident (2% vs. 1 %, p = 0.005), pulmonary infarction (26% vs. 3 %, p = 0.017), renal infarction (46% vs. 35 %, p = 0.006), acute kidney injury (70% vs. 53 %, p < 0.001), and livedo reticularis (24% vs. 17 %, p = 0.016) were significantly more frequent during CAPS events with versus without heart involvement. Multivariate analysis identified acute kidney injury (OR 1.068, IC 95 % 1.8-4.8, p < 0.001) as the only clinical characteristics that were, independently, associated with cardiac involvement in CAPS events. Cardiac involvement was not related to higher mortality. Conclusions: Cardiac involvement is frequent in CAPS, with association with kidney involvement, and it is not related to higher mortality. The presence of cardiac microthrombosis was demonstrated in most biopsies/autopsies performed.
引用
收藏
页数:7
相关论文
共 56 条
[1]   Simultaneous Left and Right Ventricular Thrombi Caused by Catastrophic Antiphospholipid Syndrome [J].
Akdime, Florie ;
Voiriot, Guillaume ;
Lalevee, Sophie ;
Blayau, Clarisse ;
Allain, Pierre Antoine ;
Djibre, Michel ;
Gibelin, Aude ;
Ederhy, Stephane ;
Fartoukh, Muriel ;
Labbe, Vincent .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 200 (12) :E147-E149
[2]   Massive Right Ventricular Thrombus Secondary to Catastrophic Antiphospholipid Syndrome [J].
Alhassan, Eaman ;
Otaishan, Dima ;
Aljohani, Sami ;
Almubarak, Mohammed .
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 (02) :E77-E78
[3]   Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines [J].
Asherson, RA ;
Cervera, R ;
de Groot, PG ;
Erkan, D ;
Boffa, MC ;
Piette, JC ;
Khamashta, MA ;
Shoenfeld, Y .
LUPUS, 2003, 12 (07) :530-534
[4]   The catastrophic antiphospholipid (Asherson's) syndrome [J].
Asherson, Ronald A. .
AUTOIMMUNITY REVIEWS, 2006, 6 (02) :64-67
[5]   Prevalence, characteristics and outcome of cardiac manifestations in critically-ill antiphospholipid syndrome patients [J].
Azoulay, Levi-Dan ;
de Chambrun, Marc Pineton ;
Larcher, Romaric ;
Pene, Frederic ;
Argaud, Laurent ;
Mayaux, Julien ;
Jamme, Matthieu ;
Coudroy, Remi ;
Mathian, Alexis ;
Gibelin, Aude ;
Azoulay, Elie ;
Tandjaoui-Lambiotte, Yacine ;
Dargent, Auguste ;
Beloncle, Francois ;
Raphalen, Jean-Herle ;
Troger, Antoine ;
de Prost, Nicolas ;
Devaquet, Jerome ;
Contou, Damien ;
Gaugain, Samuel ;
Trouiller, Pierre ;
Grange, Steven ;
Ledochowski, Stanislas ;
Lemarie, Jeremie ;
Faguer, Stanislas ;
Degos, Vincent ;
Moyon, Quentin ;
Luyt, Charles-Edouard ;
Kerneis, Mathieu ;
Combes, Alain ;
Amoura, Zahir .
JOURNAL OF AUTOIMMUNITY, 2022, 133
[6]   2023 ACR/EULAR antiphospholipid syndrome classification criteria [J].
Barbhaiya, Medha ;
Zuily, Stephane ;
Naden, Ray ;
Hendry, Alison ;
Manneville, Florian ;
Amigo, Mary-Carmen ;
Amoura, Zahir ;
Andrade, Danieli ;
Andreoli, Laura ;
Artim-Esen, Bahar ;
Atsumi, Tatsuya ;
Avcin, Tadej ;
Belmont, Michael H. ;
Bertolaccini, Maria Laura ;
Branch, D. Ware ;
Carvalheiras, Graziela ;
Casini, Alessandro ;
Cervera, Ricard ;
Cohen, Hannah ;
Costedoat-Chalumeau, Nathalie ;
Crowther, Mark ;
de Jesus, Guilherme ;
Delluc, Aurelien ;
Desai, Sheetal ;
De Sancho, Maria ;
Devreese, Katrien M. ;
Diz-Kucukkaya, Reyhan ;
Duarte-Garcia, Ali ;
Frances, Camille ;
Garcia, David ;
Gris, Jean-Christophe ;
Jordan, Natasha ;
Leaf, Rebecca K. ;
Kello, Nina ;
Knight, Jason S. ;
Laskin, Carl ;
Lee, Alfred I. ;
Legault, Kimberly ;
Levine, Steve R. ;
Levy, Roger A. ;
Limper, Maarten ;
Lockshin, Michael D. ;
Mayer-Pickel, Karoline ;
Musial, Jack ;
Meroni, Pier Luigi ;
Orsolini, Giovanni ;
Ortel, Thomas L. ;
Pengo, Vittorio ;
Petri, Michelle ;
Pons-Estel, Guillermo .
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (10) :1258-1270
[7]   ANTICARDIOLIPIN ANTIBODY AND STROKE - POSSIBLE RELATION OF VALVULAR HEART-DISEASE AND EMBOLIC EVENTS [J].
BARBUT, D ;
BORER, JS ;
WALLERSON, D ;
AMEISEN, O ;
LOCKSHIN, M .
CARDIOLOGY, 1991, 79 (02) :99-109
[8]   The Universal Definition of Heart Failure: Perspectives from Diverse Stakeholders [J].
Mentz, Robert J. ;
Lala, Anuradha .
JOURNAL OF CARDIAC FAILURE, 2021, 27 (04) :386-386
[9]   CARDIAC INVOLVEMENT IN PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME [J].
BRENNER, B ;
BLUMENFELD, Z ;
MARKIEWICZ, W ;
REISNER, SA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 18 (04) :931-936
[10]   Antiphospholipid syndrome -: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients [J].
Cervera, R ;
Piette, JC ;
Font, J ;
Khamashta, MA ;
Cervera, R ;
Piette, JC ;
Font, J ;
Khamashta, MA ;
Shoenfeld, Y ;
Camps, MT ;
Jacobsen, S ;
Lakos, G ;
Tincani, A ;
Kontopoulou-Griva, I ;
Galeazzi, M ;
Meroni, PL ;
Derksen, RHWM ;
de Groot, PG ;
Gromnica-Ihle, E ;
Baleva, M ;
Mosca, M ;
Bombardieri, S ;
Houssiau, F ;
Gris, JC ;
Quéré, I ;
Hachulla, E ;
Vasconcelos, C ;
Roch, B ;
Fernández-Nebro, A ;
Boffa, MC ;
Hughes, GRV ;
Ingelmo, M .
ARTHRITIS AND RHEUMATISM, 2002, 46 (04) :1019-1027